Sex differences in cardiovascular risk factors and cardiovascular disease in patients with hyperprolactinemia: a multicenter cross-sectional study

Key Points

• Cardiovascular disease risk factors vary between sexes in hyperprolactinemia patients, indicating crucial differences in health outcomes.
• Men with hyperprolactinemia exhibit significantly elevated cardiovascular disease risks compared to women, highlighting the need for gender-specific treatments.
• Multicenter cross-sectional study evaluates cardiovascular risk factors among patients with hyperprolactinemia across various demographics for broader insights.
• Findings suggest the necessity for further research into sex-specific management of hyperprolactinemia to improve cardiovascular health outcomes.